Strong Activation of p53 by Actinomycin D and Nutlin-3a Overcomes Resistance of Cancer Cells to the Pro-Apoptotic Activity of FAS Ligand
Preprint in Preprints.org (April 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Characterizing influence of rCHOP treatment on diffuse large B-cell lymphoma microenvironment through in vitro microfluidic spheroid model
Article in Cell Death & Disease (January 2024)
Therapeutic approaches targeting CD95L/CD95 signaling in cancer and autoimmune diseases
Article in Cell Death & Disease (March 2022)